Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin‐10‐deficient mice
暂无分享,去创建一个
[1] R. Sartor,et al. W1183 Differential In Vitro Epithelial Translocation and Resistance to Phagocyte Uptake and Killing By Escherichia coli Strains Correlate with Their Ability to Induce Colitis in Monoassociated IL-10−/− Mice , 2008 .
[2] R Balfour Sartor,et al. Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.
[3] C. Jobin,et al. Dual‐association of gnotobiotic Il‐10−/− mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis , 2007, Inflammatory bowel diseases.
[4] T. Churchill,et al. Epithelial barrier disruption allows nondisease‐causing bacteria to initiate and sustain IBD in the IL‐10 gene‐deficient mouse , 2007, Inflammatory bowel diseases.
[5] F. Shanahan,et al. Probiotic effects on inflammatory bowel disease. , 2007, The Journal of nutrition.
[6] K. Michaelsen,et al. Dose–response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults , 2006, European Journal of Clinical Nutrition.
[7] M. Sanders. Summary of Probiotic Activities of Bifidobacterium lactis HN019 , 2006, Journal of clinical gastroenterology.
[8] R. Sartor. Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.
[9] F. Shanahan,et al. Role of interleukin (IL‐10) in probiotic‐mediated immune modulation: an assessment in wild‐type and IL‐10 knock‐out mice , 2006, Clinical and experimental immunology.
[10] J. Rumessen,et al. Probiotic treatment of collagenous colitis: A randomized, double‐blind, placebo‐controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis , 2006, Inflammatory bowel diseases.
[11] C. Matuchansky,et al. Review article: bifidobacteria as probiotic agents – physiological effects and clinical benefits , 2005, Alimentary pharmacology & therapeutics.
[12] R. Bibiloni,et al. Analysis of the large bowel microbiota of colitic mice using PCR/DGGE , 2005, Letters in applied microbiology.
[13] R. Fedorak,et al. Association with Selected Bacteria Does Not Cause Enterocolitis in IL-10 Gene-Deficient Mice Despite a Systemic Immune Response , 2005, Digestive Diseases and Sciences.
[14] R. Sartor,et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. , 2005, Gastroenterology.
[15] J. Walter,et al. A High-Molecular-Mass Surface Protein (Lsp) and Methionine Sulfoxide Reductase B (MsrB) Contribute to the Ecological Performance of Lactobacillus reuteri in the Murine Gut , 2005, Applied and Environmental Microbiology.
[16] C. Jobin,et al. STAT3 regulates NF-κB recruitment to the IL-12p40 promoter in dendritic cells , 2005 .
[17] A. Iwasaki,et al. Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.
[18] A. Palva,et al. Genetic heterogeneity and functional properties of intestinal bifidobacteria , 2004, Journal of applied microbiology.
[19] Laurent Beaugerie,et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.
[20] M. Ventura,et al. Polyphasic taxonomic analysis of Bifidobacterium animalis and Bifidobacterium lactis reveals relatedness at the subspecies level: reclassification of Bifidobacterium animalis as Bifidobacterium animalis subsp. animalis subsp. nov. and Bifidobacterium lactis as Bifidobacterium animalis subsp. lactis , 2004, International journal of systematic and evolutionary microbiology.
[21] R Balfour Sartor,et al. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. , 2004, Gastroenterology.
[22] L. De Vuyst,et al. Short Fractions of Oligofructose Are Preferentially Metabolized by Bifidobacterium animalis DN-173 010 , 2004, Applied and Environmental Microbiology.
[23] C. Moskaluk,et al. Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis. , 2003, Gastroenterology.
[24] W. Hammes,et al. Safety of probiotics that contain lactobacilli or bifidobacteria. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] T. Warner,et al. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. , 2002, The American journal of pathology.
[26] P. Marteau,et al. Bifidobacterium animalis strain DN‐173 010 shortens the colonic transit time in healthy women: a double‐blind, randomized, controlled study , 2002, Alimentary pharmacology & therapeutics.
[27] R. Sartor,et al. Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice. , 2001, Gastroenterology.
[28] S. Yamazaki,et al. Probiotics and safety. , 2001, The American journal of clinical nutrition.
[29] R. Sartor,et al. Helicobacter hepaticus Does Not Induce or Potentiate Colitis in Interleukin-10-Deficient Mice , 2000, Infection and Immunity.
[30] F. Gavini,et al. A colony immunoblotting method for quantitative detection of a Bifidobacterium animalis probiotic strain in human faeces , 2000, Journal of applied microbiology.
[31] K. Wilson,et al. Differential Induction of Colitis and Gastritis in HLA-B27 Transgenic Rats Selectively Colonized with Bacteroides vulgatus or Escherichia coli , 1999, Infection and Immunity.
[32] V. Godfrey,et al. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[33] R. Sartor,et al. Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.
[34] T. Mitsuoka,et al. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. , 1998, International journal of food microbiology.
[35] R. Hammer,et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. , 1996, The Journal of clinical investigation.
[36] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.
[37] J. Lemeland,et al. Bifidobacterium from fermented milks: survival during gastric transit. , 1991, Journal of dairy science.
[38] S. Feighner,et al. Lactobacilli and bile salt hydrolase in the murine intestinal tract , 1989, Applied and environmental microbiology.
[39] P. Gopal,et al. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects. , 2007, The journal of nutrition, health & aging.
[40] R. Sartor,et al. STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. , 2005, Blood.
[41] J. Mcghee,et al. CD4 CD45RB Hi Interleukin-4 Defective T Cells Elicit Antral Gastritis and Duodenitis , 2004 .
[42] Manfred Dietel,et al. Mucosal flora in inflammatory bowel disease. , 2002, Gastroenterology.